A detailed history of Rmr Wealth Builders transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Rmr Wealth Builders holds 4,232 shares of VRTX stock, worth $1.97 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
4,232
Previous 3,748 12.91%
Holding current value
$1.97 Million
Previous $1.57 Million 26.63%
% of portfolio
0.23%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$392.81 - $485.53 $190,120 - $234,996
484 Added 12.91%
4,232 $1.98 Million
Q1 2024

Apr 15, 2024

BUY
$407.69 - $446.08 $319,221 - $349,280
783 Added 26.41%
3,748 $1.57 Million
Q4 2023

Feb 06, 2024

BUY
$343.0 - $410.68 $134,799 - $161,397
393 Added 15.28%
2,965 $1.21 Million
Q3 2023

Oct 23, 2023

BUY
$338.18 - $362.46 $869,798 - $932,247
2,572 New
2,572 $894,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Rmr Wealth Builders Portfolio

Follow Rmr Wealth Builders and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

News

Stay updated on Rmr Wealth Builders with notifications on news.